INTRO

A New Generation of Biology. Generated by AI.

With our cutting-edge artificial intelligence algorithms, proprietary experimental datasets, and wet lab R&D expertise, AIGen Therapeutics develops first-in-class therapies for the world's most deadly genetic and infectious diseases. We are at the forefront of biotechnology innovation; our artificial intelligence and data-first approaches are extending the limits of what is possible in the biological sciences today.

"What I cannot create I do not understand."

Richard Feynman
alternative

AIGen Therapeutics R&D Facilities

OUR ADVANTAGES

Focus Areas

alternative

Therapeutics Research & Development

AIGen brings together a cross functional team of researchers to innovate new medicines and biological products for deadly diseases.

  • Full stack biotechnology startup
  • State of the art research labs
  • Clinical & Research Partnerships
alternative

Proprietary Artificial Intelligence Platform

AIGen applies cutting-edge artificial intelligence and deep learning algorithms to design, build, and test first-in-class therapies for genetic and infectious diseases.

  • In-house Deep Learning Platform
  • Supercomputing Power
  • Active Learning from Proprietary Datasets
alternative

Big Data Analytics for Medicine

Our proprietary platform analyzes billions of datapoints in proteomics, genomics, and publications to make discoveries in novel classes of therapeutics.

  • We work on Biologics, antibodies, peptides, enzymes
  • Experimentally generate in-house datasets
  • Terabytes of in-vitro and clinical data
alternative
CONTACT US

Get In Touch

Interested in building the next generation of Biology, Powered By Artificial Intelligence?

Send us an email at: info (at) aigenthera.com

Copyright © AIGen Therapeutics 2020 - Page Template by Landingrepo